Supernus Pharmaceuticals (SUPN) Other Gross PP&E Adjustments (2016 - 2025)
Supernus Pharmaceuticals (SUPN) has disclosed Other Gross PP&E Adjustments for 15 consecutive years, with -$14.6 million as the latest value for Q4 2025.
- Quarterly Other Gross PP&E Adjustments fell 139.21% to -$14.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$14.6 million through Dec 2025, down 139.21% year-over-year, with the annual reading at -$14.6 million for FY2025, 139.21% down from the prior year.
- Other Gross PP&E Adjustments for Q4 2025 was -$14.6 million at Supernus Pharmaceuticals, down from -$13.5 million in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was $25.3 million in Q1 2021, with the low at -$36.4 million in Q2 2022.
- Average Other Gross PP&E Adjustments over 5 years is -$4.1 million, with a median of -$8.9 million recorded in 2021.
- Peak annual rise in Other Gross PP&E Adjustments hit 173.46% in 2021, while the deepest fall reached 251.54% in 2021.
- Over 5 years, Other Gross PP&E Adjustments stood at -$28.7 million in 2021, then surged by 39.11% to -$17.5 million in 2022, then soared by 32.87% to -$11.7 million in 2023, then skyrocketed by 48.01% to -$6.1 million in 2024, then crashed by 139.21% to -$14.6 million in 2025.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at -$14.6 million, -$13.5 million, and -$7.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.